Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Treasury Shares (2019 - 2025)

SRx Health Solutions (SRXH) has disclosed Treasury Shares for 4 consecutive years, with $76800.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares fell 95.18% year-over-year to $76800.0, compared with a TTM value of $76800.0 through Sep 2025, down 95.18%, and an annual FY2025 reading of $76800.0, changed N/A over the prior year.
  • Treasury Shares was $76800.0 for Q3 2025 at SRx Health Solutions, roughly flat from $76800.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.6 million in Q3 2024 and bottomed at $76800.0 in Q2 2025.
  • Average Treasury Shares over 3 years is $676170.6, with a median of $102597.0 recorded in 2024.
  • The sharpest move saw Treasury Shares grew 4.22% in 2024, then crashed 95.18% in 2025.
  • Year by year, Treasury Shares stood at $1.5 million in 2023, then plummeted by 93.29% to $102597.0 in 2024, then fell by 25.14% to $76800.0 in 2025.
  • Business Quant data shows Treasury Shares for SRXH at $76800.0 in Q3 2025, $76800.0 in Q2 2025, and $102597.0 in Q4 2024.